Literature DB >> 3418016

Excitatory and inhibitory actions of intrathecally administered 5-hydroxytryptamine on sympathetic nerve activity in the rat.

A P Yusof1, J H Coote.   

Abstract

In chloralose/urethane anaesthetised rats the effect of intrathecal (i.t.) administration of 5-hydroxytryptamine (5-HT) on activity in sympathetic nerves to the kidney was studied. Intrathecal 5-HT (20-100 micrograms, 10 microliter) increased activity in renal nerves (mean change for 50 micrograms dose 157% +/- 39). At higher doses of 5-HT the initial excitatory response was followed by inhibition 64% +/- 15. Intrathecally, alpha methyl 5-HT (10-400 micrograms) mimicked only the inhibitory action of 5-HT in a dose-dependent manner. These inhibitions were completely antagonised by i.t. ketanserin (25-100 micrograms). Intrathecal 2 methyl 5-HT (10-200 micrograms) had little effect on renal nerve activity. Intrathecal 5 carboxyamidotryptamine (10-200 micrograms) had a more powerful excitatory action on renal nerve activity than did 5-HT. Intrathecally, 8 OH-DPAT (10-200 micrograms) was without effect. Neither the inhibitory action of 5-HT or the excitatory action was affected by i.t. ICS 205 930 (1-10 micrograms) or MDL 72222 (200 micrograms). It was concluded that the actions of 5-HT were within the spinal cord and that the inhibitory effect on sympathetic activity is mediated via a 5-HT2-like receptor whilst the receptors involved in the excitatory action of 5-HT are not M- or 5-HT3-like but appear to be more like the 5-HT1 subtype.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3418016     DOI: 10.1016/0165-1838(88)90111-7

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  10 in total

1.  Generation of a physiological sympathetic motor rhythm in the rat following spinal application of 5-HT.

Authors:  Nephtali Marina; Melody Taheri; Michael P Gilbey
Journal:  J Physiol       Date:  2006-01-05       Impact factor: 5.182

2.  Effects of intracerebroventricular injections of 5-HT on systemic vascular resistances of conscious rats.

Authors:  Robin L Davisson; James N Bates; Alan Kim Johnson; Stephen J Lewis
Journal:  Microvasc Res       Date:  2014-08-14       Impact factor: 3.514

3.  Proceedings of the British Pharmacological Society. Leeds, 12th-14th July 1989. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

4.  The influence of 5-hydroxytryptamine agonists and antagonists on identified sympathetic preganglionic neurones in the rat, in vivo.

Authors:  D I Lewis; J H Coote
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

5.  Cardiovascular effects of intrathecal administration of agents active at 5-hydroxytryptamine1-receptors in the rat: modulation by substance P and a substance P antagonist.

Authors:  K Gradin; B Persson
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 6.  Cardiovascular responses produced by 5-hydroxytriptamine:a pharmacological update on the receptors/mechanisms involved and therapeutic implications.

Authors:  Carlos M Villalón; David Centurión
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-08-17       Impact factor: 3.000

7.  Cardiovascular effects of intrathecal administration of substance P in the rat: interactions with serotonergic mechanisms.

Authors:  K Gradin; B Persson
Journal:  J Neural Transm Gen Sect       Date:  1992

8.  Mediation of baroreceptor inhibition of sympathetic nerve activity via both a brainstem and spinal site in rats.

Authors:  D I Lewis; J H Coote
Journal:  J Physiol       Date:  1994-11-15       Impact factor: 5.182

9.  Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised cats.

Authors:  A G Ramage
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

10.  Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.

Authors:  K C Fone; A J Robinson; C A Marsden
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 9.473

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.